• Guideline Summary
  • NGC:010613
  • 1996 (revised 2014 Dec 16)

Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:009944
  • 2005 Mar 29 (revised 2013 Oct 1)

Screening for glaucoma: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:009101
  • 1996 (revised 2012 Jul 17)

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:009166
  • 1996 (revised 2012 Jun 26)

Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:010502
  • 2014 Jun

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.

  • Guideline Summary
  • NGC:010604
  • 2009 (revised 2014)

Interventions for prevention and treatment of pressure ulcers. In: Prevention and treatment of pressure ulcers: clinical practice guideline.

  • Guideline Summary
  • NGC:010911
  • 2016 Mar 1

Screening for depression in children and adolescents: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:010331
  • 2014 Feb

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α–based regimens.

  • Guideline Summary
  • NGC:010591
  • 2014 Aug

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.

  • Guideline Summary
  • NGC:010769
  • 2015 Jul

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing.

  • Guideline Summary
  • NGC:010904
  • 2016 Feb 16

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.